title: Effects of glycerol-1,2-dimethylsuccinate and propanediol-1,2-dimethylsuccinate on insulin release and protein biosynthesis in islets of Goto-Kakizaki rats.
abstract: Selected esters of succinic acid are currently under investigation as possible insulinotropic tools in the treatment of non-insulin-dependent diabetes mellitus. Novel esters with high insulinotropic efficiency were recently synthesized. The present study concerns the effects of two of these novel esters, namely glycerol-1,2-dimethylsuccinate (2.5 mM) and propanediol-1,2-dimethylsuccinate (1.0 mM), upon the release of insulin and the de novo biosynthesis of peptides in islets from hereditarily diabetic Goto-Kakizaki rats. Whereas D-glucose (2.8 to 16.7 mM) caused a concentration-related stimulation of insulin release in the islets of the diabetic rats, the two esters of succinic acid only increased modestly, and often not significantly, insulin secretion. Nevertheless, they both markedly increased the incorporation of L-[4-3H]phenylalanine into trichloroacetic acid-precipitable material in islets deprived of any other exogenous nutrient. These findings indicate that, at variance with all pharmaceutical agents presently used or proposed as insulin secretagogues in the treatment of type 2 diabetes, glycerol-1,2-dimethylsuccinate and propanediol-1,2-dimethylsuccinate, considered as islet cell nutrients, display, in addition to their insulinotropic action, the property of stimulating biosynthetic activity in the endocrine pancreas of animals affected by this disease.
authors.affiliation: Laboratory of Experimental Medicine, Brussels Free University, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: Laghmich
authors.forename: L
authors.initials: L
authors.lastname: Ladrière
authors.forename: F
authors.initials: F
authors.lastname: Malaisse-Lagae
authors.forename: W J
authors.initials: WJ
authors.lastname: Malaisse
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy / Q000235:genetics; D005947:Glucose / Q000494:pharmacology; D005989:Glycerides / Q000494:pharmacology*; D007328:Insulin / Q000097:blood*; D007515:Islets of Langerhans / Q000187:drug effects* / Q000378:metabolism; D010649:Phenylalanine / Q000378:metabolism; D011409:Propylene Glycols / Q000494:pharmacology*; D014176:Protein Biosynthesis; D051381:Rats; D013386:Succinates / Q000494:pharmacology*
chemical_list: D005989:Glycerides; D007328:Insulin; D011409:Propylene Glycols; D013386:Succinates; C110271:glycerol-1,2-dimethylsuccinate; C110272:propanediol-1,2-dimethylsuccinate; D010649:Phenylalanine; D005947:Glucose